Repligen Corp. (RGEN)
167.55
-0.85
(-0.50%)
USD |
NASDAQ |
Jan 13, 16:00
167.55
0.00 (0.00%)
After-Hours: 20:00
Repligen Price: 167.55 for Jan. 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enovis Corp. | 24.64 |
| Perspective Therapeutics, Inc. | 2.53 |
| InfuSystem Holdings, Inc. | 8.425 |
| Xtant Medical Holdings, Inc. | 0.6801 |
| VolitionRX Ltd. | 0.319 |
Price Related Metrics
| PE Ratio | 6494.19 |
| PS Ratio | 13.35 |
| Price to Book Value | 4.528 |
| Price to Free Cash Flow | 91.35 |
| Earnings Yield | 0.02% |
| Market Cap | 9.432B |
| Operating PE Ratio | 202.32 |
| Normalized PE Ratio | 279.06 |